Mental health problems: Are they or are they not a risk factor for dropout from drug treatment? A systematic review of the evidence

Drugs: Education, Prevention and Policy

Volumn 16, Issue 1, 2009, Pages 7-38

  Meier, Petra S ^a   Barrowclough, Christine ^b  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 60849131735     PISSN: 09687637     EISSN: 14653370     Source Type: Journal    
DOI: 10.1080/09687630701741030     Document Type: Article

References (82)

1. Agosti, V., Nunes, E., et al, (1996), Patient factors related to early attrition from an outpatient cocaine research clinic. American Journal of Drug and Alcohol Abuse, 22 (1), 29-39.
2. Alterman, A. I., Rutherford, M. J., et al. (1996). Response to methadone maintenance and counseling in antisocial patients with and without major depression. Journal of Nervous and Mental Disease, 184 (11), 695-702.
3. Araujo, L., Goldberg, P., et al. (1996). The effect of anxiety and depression on completion/withdrawal status in-patients admitted to substance abuse detoxification program. Journal of Substance Abuse Treatment, 13 (1), 61-66.
4. Avants, S. K., Margolin, A., et al. (1999). Day treatment versus enhanced standard methadone services for opioid-dependent patients: A comparison of clinical efficacy and cost. American Journal of Psychiatry, 156 (1), 27-33.
5. Avants, S. K., Warburton, L. A., et al. (2000). The influence of coping and depression on abstinence from illicit drug use in methadone-maintained patients. American Journal of Drug and Alcohol Abuse, 26 (3), 399-416.
6. Ball, S. A., Cobb-Richardson, P., et al. (2005). Substance abuse and personality disorders in homeless drop-in center clients: Symptom severity and psychotherapy retention in a randomized clinical trial. Comprehensive Psychiatry, 46 (5), 371-379.
7. Brady, T. M., Krebs, C. P., et al. (2004). Psychiatric comorbidity and not completing jail-based substance abuse treatment. American Journal of Addiction, 13 (1), 83-101.
8. Broome, K. M., Flynn, P. M., et al. (1999). Psychiatric comorbidity measures as predictors of retention in drug abuse treatment programs. Health Services Research, 34 (3), 791-806.
9. Bryant, K. J., Rounsaville, B., et al. (1992). Reliability of dual diagnosis. Substance dependence and psychiatric disorders. Journal of Nervous and Mental Disease, 180 (4), 251-257.
10. Cacciola, J. S., Alterman, A. I., et al. (2001). The relationship of psychiatric comorbidity to treatment outcomes in methadone maintained patients. Drug and Alcohol Dependence, 61 (3), 271-280.
11. Carroll, K. M., Ball, S. A., et al. (1993). A comparison of alternate systems for diagnosing antisocial personality disorder in cocaine abusers. Journal of Nervous and Mental Disease, 181 (7), 436-443.
12. Charney, D. A., Paraherakis, A. M., et al. (1998). The impact of depression on the outcome of addictions treatment. Journal of Substance Abuse Treatment, 15 (2), 123-130.
13. Claus, R. E., & Kindleberger, L. R. (2002). Engaging substance abusers after centralized assessment: Predictors of treatment entry and dropout. Journal of Psychoactive Drugs, 34 (1), 25-31.
14. Crawford, V. (2001). Co-existing problems of mental health and substance misuse ('dual diagnosis'). London: University College Research Unit.
15. Curran, G. M., Kirchner, J. E., et al. (2002). Depressive symptomatology and early attrition from intensive outpatient substance use treatment. Journal of Behavioral Health Services & Research, 29 (2), 138-143.
16. Darke, S., Ross, J., et al. (2005). The impact of borderline personality disorder on 12-month outcomes for the treatment of heroin dependence. Addiction, 100 (8), 1121-1130.
17. Epstein, E. E., McCrady, B. S., et al. (1994). Attrition from conjoint alcoholism treatment: Do dropouts differ from completers? Journal of Substance & Abuse, 6 (3), 249-265.
18. Franken, I. H., & Hendriks, V. M. (2001). Screening and diagnosis of anxiety and mood disorders in substance abuse patients. American Journal of Addiction, 10 (1), 30-39.
19. Galanter, M., Egelko, S., et al. (1996). Can cocaine addicts with severe mental illness be treated along with singly diagnosed addicts? American Journal of Drug & Alcohol Abuse, 22 (4), 497-507.
20. Gerra, G., Leonardi, C., et al, (2006). Buprenorphine treatment outcome in dually diagnosed heroin dependent patients: A retrospective study. Progress in Neuropsychopharmacology and Biological Psychiatry, 30 (2), 265-272.
21. Gerstley, L. J., Alterman, A. I., et al. (1990). Antisocial personality disorder in-patients with substance abuse disorders: A problematic diagnosis? American Journal of Psychiatry, 147 (2), 173-178.
22. Gill, K., Nolimal, D., et al. (1992). Antisocial personality disorder, HIV risk behavior and retention in methadone maintenance therapy. Drug and Alcohol Dependency, 30, 247-252.
23. Goldstein, M. F., Deren, S., et al. (2001). An alternative program for methadone maintenance dropouts: Description and preliminary data. Mount Sinai Journal of Medicine, 68 (1), 33-40.
24. Gonzalez, G., Feingold, A., et al. (2003). Comorbid major depressive disorder as a prognostic factor in cocaine-abusing buprenorphine-maintained patients treated with desipramine and contingency management. American Journal of Drug and Alcohol Abuse, 29 (3), 497-514.
25. Gossop, M., Marsden, J., et al. (1998). NTORS at one year. London: Department of Health.
26. Gossop, M., Marsden, J., et al. (1999a). Methadone treatment practices and outcome for opiate addicts treated in drug clinics and in general practice: Results from the National Treatment Outcome Research Study. British Journal of General Practice, 49 (438), 31-34.
27. Gossop, M., Marsden, J., et al. (1999b). Treatment retention and 1 year outcomes for residential programmes in England. Drug and Alcohol Dependence, 57 (2), 89-98.
28. Green, C. A., Polen, M. R., et al. (2002). Gender differences in predictors of initiation, retention, and completion in an HMO-based substance abuse treatment program. Journal of Substance Abuse Treatment, 23 (4), 285-295.
29. Greenberg, W., Otero, J., et al. (1994). Irregular discharges from a dual diagnosis unit. American Journal of Drug & Alcohol Abuse, 20 (3), 355-371.
30. Haller, D. L., Knisely, J. S., et al. (1997). Perinatal substance abusers: Factors influencing treatment retention. Journal of Substance Abuse Treatment, 14 (6), 513-519.
31. Haller, D. L., & Miles, D. R. (2004). Psychopathology is associated with completion of residential treatment in drug dependent women. Journal of Addictive Diseases, 23 (1), 17-28.
32. Haller, D. L., Miles, D. R., et al. (2002). Psychopathology influences treatment retention among drug-dependent women. Journal of Substance Abuse Treatment, 23 (4), 431-436.
33. Hasin, D., Samet, S., et al. (2006). Diagnosis of comorbid psychiatric disorders in substance users assessed with the Psychiatric Research Interview for Substance and Mental Disorders for DSM-IV. American Journal of Psychiatry, 163 (4), 689-696.
34. Hile, M. G., & Adkins, R. E. (1998). The impact of substance abusers' readiness to change on psychological and behavioral functioning. Addicticve Behaviors, 23, 365-370.
35. Hiller, M. L., Knight, K., et al. (1999). Prison-based substance abuse treatment, residential aftercare and recidivism. Addiction, 94 (6), 833-842.
36. Hser, Y. I., Joshi, V., et al. (2001). Effects of program and patient characteristics on retention of drug treatment patients. Evaluation & Program Planning, 24 (4), 331-341.
37. Hser, Y. I., Evans, E., et al. (2004). Relationship between drug treatment services, retention, and outcomes. Psychiatric Services, 55 (7), 767-774.
38. Joe, G. W., Simpson, D. D., et al. (1999). Retention and patient engagement models for different treatment modalities in DATOS. Drug and Alcohol Dependency, 57 (2), 113-125.
39. King, V. L., Brooner, R. K., et al. (1999). Attention deficit hyperactivity disorder and treatment outcome in opioid abusers entering treatment. Journal of Nervous and Mental Disease, 187 (8), 487-495.
40. King, V. L., Kidorf, M. S., et al. (2001). Influence of antisocial personality subtypes on drug abuse treatment response. Journal of Nervous and Mental Diseases, 189 (9), 593-601.
41. (2004)Identifying pregnant women at risk for early attrition from substance abuse treatment. Journal of Substance Abuse Treatment, 27(1), 31-38.
42. Klein, C., di Menza, S., et al. (2002). Interaction effects of treatment setting and client characteristics on retention and completion. Journal of Psychoactive Drugs, 34 (1), 39-50.
43. Kleinman, P. H., Kang, S. Y., et al. (1992). Retention of cocaine abusers in outpatient psychotherapy. American Journal of Drug and Alcohol Abuse, 18 (1), 29-43.
44. Knight, D. K., Logan, S. M., et al. (2001). Predictors of program completion for women in residential substance abuse treatment. American Journal of Drug and Alcohol Abuse, 27 (1), 1-18.
45. Kokkevi, A., Stefanis, N., et al. (1998). Personality disorders in drug abusers: Prevalence and their association with AXIS-I disorders as predictors of treatment retention. Addictive Behaviours, 23 (6), 841-853.
46. Lang, M. A., & Belenko, S. (2000). Predicting retention in a residential drug treatment alternative to prison program. Journal of Substance Abuse Treatment, 19 (2), 145-160.
47. Laudet, A. B. (2003). Attitudes and beliefs about 12-step groups among addiction treatment clients and clinicians: Toward identifying obstacles to participation. Substance Use & Misuse, 38 (14), 2017-2047.
48. Lewin, T. J., Baker, A. L., et al. (2004). The 'comorbidity roundabout': A framework to guide assessment and intervention strategies and engineer change among people with comorbid problems. Drug and Alcohol Review, 23, 307-423.
49. Lowe, A. L., & Abou-Saleh, M. T. (2004). The British experience of dual diagnosis in the National Health Service. Acta Neuropsychiatrica, 16, 41-46.
50. Magura, S., Nwakeze, P. C., & Demsky, S. Y. (1998). Pre-and in-treatment predictors of retention in methadone treatment using survival analysis. Addiction, 93, 51-60.
51. Manning, V., Strathdee, G., et al. (2002). Dual diagnosis screening: Preliminary findings on the comparison of 50 clients attending community mental health services and 50 clients attending community substance misuse services. Journal of Substance Use, 7 (4), 221-228.
52. Maremmani, I., Zolesi, O., et al. (2000). Methadone dose and retention during treatment of heroin addicts with Axis-I psychiatric comorbidity. Journal of Addictive Diseases, 19 (2), 29-41.
53. Marlowe, D. B., Kirby, K. C, et al. (1997). Impact of comorbid personality disorders and personality disorder symptoms on outcomes of behavioral treatment for cocaine dependence. Journal of Nervous and Mental Disease, 185 (8), 483-490.
54. Marsden, J., Gossop, M., et al. (2000). Psychiatric symptoms among clients seeking treatment for drug dependence. Intake data from the National Treatment Outcome Research Study. British Journal of Psychiatry, 176, 285-289.
55. Martinez-Raga, J., Marshall, E. J., et al. (2002). Unplanned versus planned discharges from in-patient alcohol detoxification: Retrospective analysis of 470 first-episode admissions. Alcohol Abuse, 37 (3), 277-281.
56. McCaul, M. E., Svikis, D. S., et al. (2001). Predictors of outpatient treatment retention: Patient versus substance use characteristics. Drug and Alcohol Dependency, 62, 9-17.
57. Meier, P. S., & Best, D. (2006). Programme factors that influence completion of residential treatment. Drug and Alcohol Review, 25, 349-355.
58. Meier, P. S., Donmall, M. C., et al. (2006). The role of the early therapeutic alliance in predicting drug treatment dropout. Drug and Alcohol Dependence, 83 (1), 57-64.
59. Mertens, J. R., & Weisner, C. M. (2000). Predictors of substance abuse treatment retention among women and men in an HMO. Alcoholism: Clinical and Experimental Research, 24 (10), 1525-1533.
60. Mierlak, D., Galanter, M., et al. (1998). Modified therapeutic community treatment for homeless dually diagnosed men. Who completes treatment? Journal of Substance Abuse Treatment, 15 (2), 117-121.
61. Moos, R. H., & King, M. J. (1997). Participation in community residential treatment and substance abuse patients' outcomes at discharge. Journal of Substance Abuse Treatment, 14 (1), 71-80.
62. Nuttbrock, L. A., Rahav, M., et al. (1998). Outcomes of homeless mentally ill chemical abusers in community residences and a therapeutic community. Psychiatric Services, 49 (1), 68-76.
63. Pani, P. P., Trogu, E., Contu, P., Agus, A., & Gessa, G. L. (1997). Psychiatric severity and treatment response in a comprehensive methadone maintenance treatment program. Drug and Alcohol Dependence, 48, 119-126.
64. Petty, N. M., & Bickel, W. K. (1999). Therapeutic alliance and psychiatric severity as predictors of completion of treatment for opioid dependence. Psychiatric Services, 50 (2), 219-227.
65. Ravndal, E., & Vaglum, P. (1991). Psychopathology and substance abuse as predictors of program completion in a therapeutic community for drug abusers: A prospective study. Acta Psychiatrica Scandinavica, 83, 217-222.
66. Ross, H. E., Cutler, M., et al. (1997). Retention in substance abuse treatment. Role of psychiatric symptom severity. American Journal of Addiction, 6 (4), 293-303.
67. Ryan, R. M., Plant, R. W., et al. (1995). Initial motivations for alcohol treatment: Relations with patient characteristics, treatment involvement, and dropout. Addictive Behaviours, 20 (3), 279-297.
68. Saxon, A. J., & Calsyn, D. A. (1995). Effects of psychiatric care for dual diagnosis patients treated in a drug dependence clinic. American Journal of Drug and Alcohol Abuse, 21 (3), 303-313.
69. Saxon, A. J., Wells, E. A., et al. (1996). Pretreatment characteristics, program philosophy and level of ancillary services as predictors of methadone maintenance treatment outcome. Addiction, 91 (8), 1197-1209.
70. Sayre, S. L., Schmitz, J. M., et al. (2002). Determining predictors of attrition in an outpatient substance abuse program. American Journal of Drug and Alcohol Abuse, 28 (1), 55-72.
71. Schulte, S. (2007). Treatment Options and Pathways for clients with Comorbidity (TOPCOM): A national survey. Manchester, UK: Manchester Metropolitan University.
72. Simpson, D. D., Joe, G. W., et al. (1997). Drug abuse treatment retention and process effects on follow-up outcomes. Drug and Alcohol Dependence, 47 (3), 227-235.
73. Siqueland, L., Crits-Christoph, P., et al. (1998). Predictors of dropout from psychosocial treatment of cocaine dependence. Drug and Alcohol Dependence, 52 (1), 1-13.
74. Siqueland, L., Crits-Christoph, P., et al. (2002). Retention in psychosocial treatment of cocaine dependence: Predictors and impact on outcome. American Journal of Addiction, 11 (1), 24-40.
75. Stark, M. J. (1992). Dropping out of substance abuse treatment: A clinically oriented review. Clinical Psychology Review, 12, 93-116.
76. Tidey, J. W., Mehl-Madrona, L., et al. (1998). Psychiatric symptom severity in cocaine-dependent outpatients: Demographics, drug use characteristics and treatment outcome. Drug and Alcohol Dependence, 50 (1), 9-17.
77. Van Stelle, K. R., Blumer, C., & Moberg, D. P. (2004). Treatment retention of dually diagnosed offenders in an institutional therapeutic community. Behavioral Sciences & the Law, 22 (4), 585-97.
78. Virgo, N., Bennett, G., et al. (2001). The prevalence and characteristics of co-occurring serious mental illness (SMI) and substance abuse or dependence in the patients of Adult Mental Health and Addictions Services in eastern Dorset. Journal of Mental Health, 10 (2), 175-188.
79. Wallace, A. E., & Weeks, W. B. (2004). Substance abuse intensive outpatient treatment: Does program graduation matter? Journal of Substance Abuse Treatment, 27 (1), 27-30.
80. Weaver, T., Madden, P., et al. (2003). Comorbidity of substance misuse and mental illness in community mental health and substance misuse services. British Journal of Psychiatry, 183, 304-313.
81. Williamson, P. R., & Gamble, C. (2005). Identification and impact of outcome selection bias in meta-analysis. Statistics in Medicine, 24, 1547-1561.
82. Zhang, Z., Friedmann, P. D., et al. (2003). Does retention matter? Treatment duration and improvement in drug use. Addiction, 98 (5), 673-684.